Status:
COMPLETED
Surgical Therapy and Survival in HCC/ C.F. Zhang et al.
Lead Sponsor:
Linzhu Zhai
Conditions:
Hepatocellular Carcinoma
Surgery
Eligibility:
All Genders
18-45 years
Brief Summary
This study utilizes a new method to explore compare the overall survival (OS) and cancer-specific survival (CSS) in patients aged 18-45 years with stage I-II HCC who underwent different types of surge...
Detailed Description
The SEER data contain no identifiers and are publicly available for studies of cancer-based epidemiology and survival analysis. Therefore, the current study was deemed to be exempt from Institutional ...
Eligibility Criteria
Inclusion
- Patients were diagnosed with colorectal cancer only;
- Patients with simultaneous metastasis of liver and lung cancer cells;
- Patients without metastasis resection;
- whether they underwent palliative primary tumor resection was known;
- Their cause of death was known;
- Their survival time were known and greater than 0 month;
- Patients were diagnosed with microscopic confirmation.
Exclusion
- No
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
664 Patients enrolled
Trial Details
Trial ID
NCT04820712
Start Date
September 1 2020
End Date
January 1 2021
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
linzhu Zhai
Guangzhou, Guangdong, China, 510405